{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:22:35Z","timestamp":1788214955764,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","award":["2018YFC1704305"],"award-info":[{"award-number":["2018YFC1704305"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>In recent years, the incidence of ulcerative colitis (UC) is on the rise, and most of them are young adults. As the peak of the disease overlaps with the childbearing age, it has a great impact on the fertility of female patients. We, therefore, conduct a randomized and controlled trial to evaluate the efficacy and safety of mesalazine enteric-coated tablets combined with Kangfuxin Liquid (KFX) enema for the child-bearing period female with active UC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this randomized controlled study, a total of 236 eligible patients will be assigned to the experimental group (n\u200a=\u200a118) or the control group (n\u200a=\u200a118) in a 1:1 ratio. The control group will be taken mesalazine enteric-coated tablets combined with placebo enema and the experimental group will be taken mesalazine enteric-coated tablets combined with KFX enema. Participants will receive 8 weeks of intervention treatment and 3 months of maintenance treatment before pregnancy. The primary assessment is the Mayo score. Secondary outcomes include mucosal healing, faecal calprotectin (FC), Inflammatory Bowel Disease Quality (IBDQ), and pregnancy outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>This study will provide evidence regarding the efficacy and safety of KFX enema used before pregnancy on halting active UC, reducing the relapse rate during pregnancy, improving pregnancy outcome, and the quality of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>Chinese Clinical Trials Register identifier, ChiCTR2000039161, registered on October 20, 2020.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023915","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T19:41:59Z","timestamp":1614109319000},"page":"e23915","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis"],"prefix":"10.1097","volume":"100","author":[{"given":"Tong","family":"Wang","sequence":"first","affiliation":[{"name":"College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Lu","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Li","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e20909","DOI":"10.1097\/MD.0000000000020909","article-title":"The efficacy of acupuncture for the treatment and the fertility improvement in child-bearing period female with Hashimoto Disease: a randomized controlled study","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R2-20250504","first-page":"647","article-title":"Long-term follow-up of ulcerative colitis in the Chinese population","volume":"104","author":"Chow","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00535-019-01603-8","article-title":"Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey","volume":"54","author":"Murakami","year":"2019","journal-title":"J Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00365529108998621","article-title":"Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987","volume":"26","author":"Langholz","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ibd.21369","article-title":"Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden","volume":"17","author":"Stephansson","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2169\/internalmedicine.8550-16","article-title":"Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: a retrospective evaluation","volume":"57","author":"Ito","year":"2018","journal-title":"Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e17309","DOI":"10.1097\/MD.0000000000017309","article-title":"The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: a systematic review and meta-analysis","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"56","author":"Ornish","year":"2007","journal-title":"Gut"},{"key":"R9-20250504","first-page":"2006","article-title":"Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study","volume":"98","author":"N\u00f8rg\u00e5rd","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jfprhc-2014-101000","article-title":"Disease-related pregnancy concerns and reproductive planning in women with inflammatory bowel diseases","volume":"41","author":"Gawron","year":"2015","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ibd\/izx004","article-title":"The influence of hormonal fluctuation on inflammatory bowel disease symptom severity\u2014a cross-sectional cohort study","volume":"24","author":"Rolston","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/apt.12417","article-title":"Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease","volume":"38","author":"Abhyankar","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ibd\/izy143","article-title":"Influences and impact of anxiety and depression in the setting of inflammatory bowel disease","volume":"24","author":"Navabi","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression","volume":"68","author":"Frolkis","year":"2019","journal-title":"Gut"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/ibd\/izy202","article-title":"Development of a sexual dysfunction scale for women with inflammatory bowel disease","volume":"24","author":"de Silva","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1751-2980.12247","article-title":"Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery","volume":"16","author":"Bharadwaj","year":"2015","journal-title":"J Dig Dis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto Consensus Statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1756-0500-6-210","article-title":"Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis [J]","volume":"6","author":"Ujihara","year":"2013","journal-title":"BMC Res Notes"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/ecco-jcc\/jjw049","article-title":"Ulcerative colitis remission status after induction with mesalazine predicts maintenance outcomes: the MOMENTUM trial","volume":"10","author":"Rubin","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5217\/ir.2017.15.3.368","article-title":"Comparison of efficacy of multimatrix mesalazine 4.8 g\/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study","volume":"15","author":"Ogata","year":"2017","journal-title":"Intest Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e21903","DOI":"10.1097\/MD.0000000000021903","article-title":"Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: a multi-center, randomized, double-blind, controlled trial","volume":"99","author":"Kou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jep.2011.08.057","article-title":"Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study","volume":"141","author":"Gong","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2013.08.006","article-title":"Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis\u2014a randomized, placebo-controlled, pilot study","volume":"8","author":"Singla","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/abbs\/gmy024","article-title":"Anti-fibrotic role and mechanism of Periplaneta americana extracts in CCl4-induced hepatic fibrosis in rats","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000488535","article-title":"Periplaneta Americana extract may attenuate renal fibrosis through inhibiting Janus tyrosine kinase 2\/signal transducer and activator of transcription 3 pathway","volume":"102","author":"Liu","year":"2018","journal-title":"Pharmacology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13020-019-0259-4","article-title":"The crude ethanol extract of Periplaneta americana L. stimulates wound healing in vitro & in vivo","volume":"14","author":"Li","year":"2019","journal-title":"Chin Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/13880209.2019.1682620","article-title":"Gastroprotective effects of Kangfuxin against water-immersion and restraint stress-induced gastric ulcer in rats: roles of antioxidation, anti-inflammation, and pro-survival","volume":"57","author":"Lu","year":"2019","journal-title":"Pharm Biol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"6019530","DOI":"10.1155\/2017\/6019530","article-title":"Kangfuxinye enema combined with mesalamine for ulcerative colitis: a systematic review and GRADE approach","volume":"2017","author":"Ren","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3109\/13880209.2016.1170862","article-title":"Protective effect of Periplaneta americana extract in ulcerative colitis rats induced by dinitrochlorobenzene and acetic acid","volume":"54","author":"Li","year":"2016","journal-title":"Pharm Biol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fphar.2018.00944","article-title":"Periplaneta americana Ameliorates Dextran Sulfate sodium-induced ulcerative colitis in rats by Keap1\/Nrf-2 activation, intestinal barrier function, and gut microbiota regulation","volume":"9","author":"Ma","year":"2018","journal-title":"Front Pharmacol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"119846","DOI":"10.1016\/j.ijpharm.2020.119846","article-title":"Temperature-sensitive hydrogel for rectal perfusion improved the therapeutic effect of Kangfuxin liquid on DSS-induced ulcerative colitis mice: the inflammation alleviation and the colonic mucosal barriers repair","volume":"589","author":"Xue","year":"2020","journal-title":"Int J Pharm"},{"key":"R33-20250504","first-page":"279","article-title":"Ethical principles for the guidance of physicians in medical research\u2014the Declaration of Helsinki","volume":"79","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"2001","journal-title":"Bull World Health Organ"},{"key":"R34-20250504","first-page":"796","article-title":"Chinese consensus on diagnosis and treatment of inflammatory bowel disease (Beijing, 2018)","volume":"38","author":"Wu","year":"2018","journal-title":"Chin J Pract Intern Med"},{"key":"R35-20250504","first-page":"77","article-title":"Efficacy of oral mesalazine combined with Kangfuxin liquid retention enema in the treatment of ulcerative colitis[J]","volume":"17","author":"Su","year":"2019","journal-title":"Chin Geriatr Healthc Med"},{"key":"R36-20250504","first-page":"400","article-title":"Clinical observation of mesalazine combined with Kangfuxin liquid in the treatment of ulcerative colitis[J]","volume":"22","author":"Ouyang","year":"2014","journal-title":"Chin J Integr Tradit Chin Western Med Digest"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12325-016-0303-z","article-title":"Mesalazine modified-release tablet in the treatment of ulcerative colitis in the active phase: a Chinese, multicenter, single-blind, randomized controlled study","volume":"33","author":"Sun","year":"2016","journal-title":"Adv Ther"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"New Engl J Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12876-015-0244-z","article-title":"Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child?\u2014A systematic review","volume":"15","author":"De Lima","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2016.10.016","article-title":"Outcomes of pregnancies for women undergoing endoscopy while they were pregnant: a nationwide cohort study","volume":"152","author":"Ludvigsson","year":"2017","journal-title":"Gastroenterology"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/ibd\/izx055","article-title":"Fecal calprotectin during pregnancy in women with moderate-severe inflammatory bowel disease","volume":"24","author":"Kammerlander","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ibd.20392","article-title":"Analysis of bacterial bowel communities of IBD patients: what has it revealed?","volume":"14","author":"Sokol","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"issue":"(Suppl 1)","key":"R45-20250504","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/mi.2008.46","article-title":"Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of proinflammatory interleukin-13 on epithelial cell function","volume":"1","author":"Heller","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"(Pt 22)","key":"R46-20250504","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1242\/jcs.02630","article-title":"Interferon- selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores","volume":"118","author":"Watson","year":"2005","journal-title":"J Cell Sci"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mi.2017.31","article-title":"MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation","volume":"11","author":"Ho","year":"2018","journal-title":"Mucosal Immunol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/ibd\/izy095","article-title":"Mitochondrial DNA is a proinflammatory damage-associated molecular pattern released during active IBD","volume":"24","author":"Boyapati","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-017-01973-8","article-title":"Meta-analysis of gut microbiome studies identifies disease-specific and shared responses","volume":"8","author":"uvallet","year":"2017","journal-title":"Nat Commun"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn's disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"109753","DOI":"10.1016\/j.biopha.2019.109753","article-title":"Antipyretic, anti-inflammatory and analgesic activities of Periplaneta americana extract and underlying mechanisms","volume":"123","author":"Nguyen","year":"2020","journal-title":"Biomed Pharmacother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:15:36Z","timestamp":1746339336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023915"}},"subtitle":["A protocol for randomized, double-blind, controlled trial"],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023915","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"2020-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}